Latest Market News

Volt Group Limited reported a robust 20% increase in FY24 revenue receipts, driven by strong EcoQuip growth and strategic contract wins, while advancing its zero-emission ATEN technology with promising trials underway.

Finder Energy reports significant progress in its Kuda Tasi and Jahal oil fields development, including promising production simulations and active partner engagement for funding. The company also advances exploration efforts in the UK North Sea and Australia, maintaining a solid cash position.

Sayona Mining's latest 2024 drilling results at North American Lithium reveal significant high-grade lithium intersections, underscoring potential resource upgrades and expansions in Québec.

Almonty Industries has locked in final commitments for an AUD 18.45 million equity placement from existing shareholders, aiming to strengthen its financial position and cover offer costs. The placement includes warrants and options, with closing pending regulatory approval.

CuFe Ltd has completed the sale of its JWD iron ore rights and Crossroads gold royalty, while forging a strategic alliance to advance copper and gold projects in Tennant Creek. These moves position the company for focused exploration and development in 2025.

Sayona Mining’s December 2024 quarterly report reveals robust operational gains at North American Lithium, a successful $38 million capital raise, and a transformative merger agreement with Piedmont Lithium.

AuMEGA Metals has unveiled plans for a major 2025 drilling program focused on its Bunker Hill project, backed by a successful C$16 million private placement. Recent exploration results highlight promising gold and copper targets across its Newfoundland portfolio.

Titomic Limited has secured AUD 30 million in equity funding and appointed new leadership as it establishes a U.S. headquarters in Huntsville, Alabama, aiming to capitalize on growing aerospace and defense demand.

Caravel Minerals has secured a crucial water licence agreement and progressed its feasibility study, alongside raising $5 million to support the Caravel Copper Project's development in Western Australia.

Paradigm Biopharmaceuticals has appointed Advanced Clinical as the Clinical Research Organisation for its critical Phase 3 trial targeting knee osteoarthritis pain, setting the stage for patient recruitment and dosing in Q2 2025.

First Graphene Limited reports a robust December quarter with new patents, expanded distribution networks, and advancing commercial trials, positioning the company on a path to cash breakeven.

Adisyn Ltd has completed its transformative acquisition of 2D Generation, securing a $10 million capital raise to accelerate development of graphene-enhanced semiconductor technologies. The company is positioning itself to disrupt key markets including defence, data centres, and cybersecurity.